A comparative study to assess two doses of a novel aldose reductase inhibitor (ARI)/Antioxidant drug candidate Cemtirestat, the current ARI drug Epalrestat, and the antioxidant Stobadine on Fructose- and Streptozotocin-Induced hepatic and pancreatic stress responses in rats
一项比较研究，旨在评估两种剂量的新型醛糖还原酶抑制剂（ARI）/抗氧化剂候选药物Cemtirestat、现有ARI药物Epalrestat和抗氧化剂Stobadine对果糖和链脲佐菌素诱导的大鼠肝脏和胰腺应激反应的影响。
期刊:Journal of Diabetes and Metabolic Disorders
影响因子:1.6
doi:10.1007/s40200-025-01723-4
Dagistanli, Fatma Kaya; Ceylan, Asli F; Elmazoglu, Zubeyir; Efendiyeva, Nigar; Sarıbaş, Sanem Gülistan; Pilafi, Belisa Kaleci; Stefek, Milan; Ulusu, Nuriye Nuray; Karasu, Çimen
